mesenchymal stem cells
-
Biologics
BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing
–License will enable expanded clinical operations for investigator-initiated trials and potential “right to try” uses of BRTX-100.— MELVILLE, N.Y., May 31,…
Read More » -
Biologics
SpinalCyte Announces Publication of Fibroblast Cell Therapy Review in the Journal of Translational Medicine
July 31, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human…
Read More » -
Extremities
Study: Healing outcomes after rotator cuff repair significantly improve with MSC therapy
LAS VEGAS — Use of bone marrow concentrate containing mesenchymal stem cells as an adjunct therapy showed significant improvement in…
Read More »